 Shares of Apyx Medical NASDAQ:APYX remained unaffected after the company reported Q2 results.Quarterly Results Earnings per share were down 7.69 year over year to 0.14, which beat the estimate of 0.21.Revenue of 4,296,000 declined by 34.59 from the same period last year, which beat the estimate of 1,960,000.Guidance Apyx Medical hasnt issued any earnings guidance for the time being.Apyx Medical hasnt issued any revenue guidance for the time being.How To Listen To The Conference Call Date: Aug 10, 2020View more earnings on APYXTime: 08:00 AMET Webcast URL: Action 52-week high: 8.59Companys 52-week low was at 2.81Price action over last quarter: Up 55.28Company Profile Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctors offices, surgery centers, and hospitals. The companys product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing OEM. Its Advanced Energy segment derives majority revenue.See more from Benzinga PE Ratio Insights for Apyx Medical 17 Healthcare Stocks Moving In Tuesdays Pre-Market SessionC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 